Inagi, Japan

Noriyuki Misaki

This inventor holds 1 USPTO granted patent. Top assignees: Grelan Pharmaceutical Co., Ltd., Nisshin Flour Milling Co., Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Misaki. Retrieved from https://idiyas.com/inventor/noriyuki-misaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriyuki Misaki: Innovator in Anti-Ulcer Agents

Introduction

Noriyuki Misaki is a notable inventor based in Inagi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer agents. His innovative work has led to the creation of a patent that addresses important health concerns.

Latest Patents

Misaki holds a patent for "Isoprenoid derivatives and anti-ulcer agents containing the same." This patent focuses on anti-ulcer agents that incorporate isoprenoid derivatives. The isoprenoid derivatives are represented by a specific chemical formula, which includes various groups that can be hydrogen atoms, hydroxy groups, lower alkanoyloxy groups, lower alkyl groups, or lower alkoxy groups. The patent emphasizes the importance of these derivatives in the formulation of effective anti-ulcer medications. He has 1 patent to his name.

Career Highlights

Throughout his career, Misaki has worked with prominent companies in the pharmaceutical and food industries. Notable among these are Nisshin Flour Milling Co., Ltd. and Grelan Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions for health-related issues.

Collaborations

Misaki has collaborated with esteemed colleagues, including Kazuhiko Yamada and Yoshiyuki Tahara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Noriyuki Misaki's contributions to the development of anti-ulcer agents highlight his innovative spirit and dedication to improving health outcomes. His patent and collaborations reflect his commitment to advancing pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…